{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:52:43Z","timestamp":1761155563599,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.revmed.2012.01.003","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T07:38:53Z","timestamp":1329205133000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Grossesse et syndrome des antiphospholipides"],"prefix":"10.1016","volume":"33","author":[{"given":"N.","family":"Costedoat-Chalumeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Guettrot-Imbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Leguern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Le Thi Huong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Vauthier-Brouzes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dommergues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cornet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Auma\u00eetre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Pourrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Piette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nizard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2012.01.003_bib0005","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.01.003_bib0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1016\/j.revmed.2012.01.003_bib0015","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.revmed.2011.02.012","article-title":"Syndrome des antiphospholipides et grossesse","volume":"32","author":"Arnaud","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.01.003_bib0020","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.01.003_bib0025","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/ard.2008.093179","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients","volume":"68","author":"Cervera","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2012.01.003_bib0030","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/deh844","article-title":"Recurrent miscarriage and long-term thrombosis risk: a case-control study","volume":"20","author":"Quenby","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.revmed.2012.01.003_bib0035","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C","article-title":"High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin","volume":"44","author":"Erkan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.01.003_bib0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jri.2006.12.003","article-title":"The obstetric antiphospholipid syndrome","volume":"77","author":"Derksen","year":"2008","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.revmed.2012.01.003_bib0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0301-2115(97)02736-X","volume":"73","author":"Faden","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.revmed.2012.01.003_bib0050","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0002-9378(97)70409-5","article-title":"Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial","volume":"176","author":"Cowchock","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.revmed.2012.01.003_bib0055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/annrheumdis-2011-200614","article-title":"Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called \u2018seronegative APS\u2019)","volume":"71","author":"Rodriguez-Garcia","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2012.01.003_bib0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0961203309347794","article-title":"Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome","volume":"19","author":"Bramham","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2012.01.003_bib0065","series-title":"Systemic lupus erythematosus","first-page":"1015","article-title":"Pregnancy and antiphospholipid syndrome","author":"Milan","year":"2010"},{"key":"10.1016\/j.revmed.2012.01.003_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2393-9-11","article-title":"Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset","volume":"9","author":"Nodler","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.revmed.2012.01.003_bib0075","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/bmj.330.7491.576","article-title":"The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community","volume":"330","author":"Milne","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2012.01.003_bib0080","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1067\/mob.2001.113846","article-title":"Antiphospholipid antibodies in women at risk for preeclampsia","volume":"184","author":"Branch","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.revmed.2012.01.003_bib0085","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.lpm.2008.08.001","article-title":"Grossesse et anticorps antiphospholipides","volume":"37","author":"Le Guern","year":"2008","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2012.01.003_bib0090","first-page":"2025","article-title":"A study of 75 pregnancies in patients with antiphospholipid syndrome","volume":"28","author":"Huong","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2012.01.003_bib0095","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.revmed.2008.09.012","article-title":"Pathologies hepatiques et grossesse","volume":"30","author":"Delluc","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.01.003_bib0100","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/ard.2006.061671","article-title":"Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases","volume":"66","author":"Gomez-Puerta","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2012.01.003_bib0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2003.019000","article-title":"The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women","volume":"64","author":"Le Thi Huong","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"10.1016\/j.revmed.2012.01.003_bib0285","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.revmed.2011.03.083","article-title":"Syndrome catastrophique des antiphospholipides (CAPS) et grossesse\u00a0: s\u00e9rie monocentrique r\u00e9trospective de 9\u00a0patientes","volume":"32","author":"Hanouna","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.01.003_bib0115","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2012.01.003_bib0120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry\u201d","volume":"32","author":"Cervera","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2012.01.003_bib0125","unstructured":"http:\/\/www.afssaps.fr\/Infos-de-securite\/Recommandations-de-bonne-pratique\/Prevention-et-traitement-de-la-maladie-thromboembolique-veineuse-en-medecine-recommandations-de-bonne-pratique. Novembre 2009."},{"key":"10.1016\/j.revmed.2012.01.003_bib0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/1464727992000199731","article-title":"Antiphospholipid antibodies and infertility","volume":"5","author":"Backos","year":"2002","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.revmed.2012.01.003_bib0135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/rheumatology\/kei159","article-title":"The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and\/or the antiphospholipid syndrome","volume":"45","author":"Le Thi Huong","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2012.01.003_bib0140","first-page":"S403","article-title":"Absence of lupus anticoagulant is a strong predictor of uncomplicated pregnancy in patients with APL antibodies","volume":"59","author":"Salmon","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.01.003_bib0145","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2012.01.003_bib0150","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/rheumatology\/kel212","article-title":"Uterine artery Doppler in predicting pregnancy outcome in women with connective tissue disorders","volume":"45","author":"Castellino","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2012.01.003_bib0155","first-page":"235","article-title":"Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome","volume":"98","author":"Venkat-Raman","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.revmed.2012.01.003_bib0160","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2012.01.003_bib0165","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/j.1538-7836.2010.04015.x","article-title":"Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy","volume":"8","author":"Cohn","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2012.01.003_bib0170","first-page":"CD002859","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2012.01.003_bib0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","article-title":"A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy","volume":"182","author":"Branch","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.revmed.2012.01.003_bib0180","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/art.10957","article-title":"Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies","volume":"48","author":"Triolo","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.01.003_bib0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.8755-8920.2001.450309.x","article-title":"Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin","volume":"45","author":"Vaquero","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.revmed.2012.01.003_bib0190","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin","volume":"26","author":"Stephenson","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.revmed.2012.01.003_bib0195","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin","volume":"83","author":"Noble","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.revmed.2012.01.003_bib0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijgo.2010.09.010","article-title":"Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome","volume":"112","author":"Fouda","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.revmed.2012.01.003_bib0205","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/humrep\/deh115","article-title":"Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control","volume":"19","author":"Carlin","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.revmed.2012.01.003_bib0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2012.01.003_bib0215","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First trimester low dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.01.003_bib0220","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.01.003_bib0225","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.revmed.2010.08.018","article-title":"Hydroxychloroquine\u00a0: une nouvelle approche therapeutique des manifestations thrombotiques du syndrome des antiphospholipides","volume":"31","author":"Szymezak","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.01.003_bib0230","unstructured":"Le CRAT. http:\/\/www.lecrat.org\/. Acc\u00e8s 2011."},{"key":"10.1016\/j.revmed.2012.01.003_bib0235","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/clpt.2008.73","article-title":"Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy","volume":"84","author":"Lebaudy","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl. 3","key":"10.1016\/j.revmed.2012.01.003_bib0240","first-page":"iii23","article-title":"Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers","volume":"47","author":"Erkan","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2012.01.003_bib0245","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.01.003_bib0250","series-title":"Systemic lupus erythematosus","first-page":"1061","article-title":"Antimalarials and systemic lupus erythematosus","author":"Costedoat-Chalumeau","year":"2010"},{"key":"10.1016\/j.revmed.2012.01.003_bib0255","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/bmj.315.7104.372","article-title":"Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery","volume":"315","author":"Piette","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2012.01.003_bib0260","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/art.22663","article-title":"Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals","volume":"56","author":"Erkan","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.01.003_bib0265","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/art.23160","article-title":"Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al.","volume":"58","author":"Wahl","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.01.003_bib0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.01.003_bib0275","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/ard.2008.090670","article-title":"Complement activation in patients with primary antiphospholipid syndrome","volume":"68","author":"Oku","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2012.01.003_bib0280","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/pd.2227","article-title":"Impact of antiphosholipid biology in maternal Down syndrome screening","volume":"29","author":"Brochet","year":"2009","journal-title":"Prenat Diagn"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:29:43Z","timestamp":1759336183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866312000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0248866312000045"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2012.01.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Grossesse et syndrome des antiphospholipides","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2012.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Soci\u00e9t\u00e9 nationale Fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}